Novartis Ag (NVSEF) Net Cash Flow Growth (5y) (2014 - 2025)

Novartis Ag (NVSEF) Net Cash Flow Growth (5y) (2014 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -19.54%
Jun 30, 2025 -20.88%
Dec 31, 2024 -74.57%
Jun 30, 2024 -60.08%
Dec 31, 2023 75.20%
Sep 30, 2023 -3.49%
Jun 30, 2023 -16.69%
Dec 31, 2022 -54.63%
Jun 30, 2022 -108.36%
Dec 31, 2021 -38.52%
Sep 30, 2021 -3.73%
Jun 30, 2021 33.13%
Mar 31, 2021 27.67%
Dec 31, 2019 1,096.54%
Jun 30, 2019 1,082.96%
Dec 31, 2018 2,186.41%
Sep 30, 2018 -1,462.37%
Jun 30, 2018 2,493.05%
Dec 31, 2014 -68.50%
Sep 30, 2014 18.53%